Iberogas

Bitter Candytuft Fresh Plant Extract, the active ingredient in Iberogas, is a herbal presented as an oral preparation for oral use. It is marketed as a dietary supplement and does not have a specific therapeutic indication in regulated medicine. GNH USA supplies Iberogas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iberogas is an herbal product without a defined pharmacological target; it is generally marketed as a dietary supplement for general wellness.

No specific therapeutic indication: sold as a herbal supplement for general wellness. Traditional digestive comfort: used historically to support mild gastrointestinal discomfort. Traditional respiratory soothing: used historically to alleviate occasional throat irritation. Traditional stress relief: used historically for mild calming effects.

Iberogas is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Gastrointestinal upset: mild nausea or stomach discomfort. - Allergic skin reactions: itching or rash at the site of contact. - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Mouth irritation: tingling or burning sensation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatic injury: uncommon liver enzyme elevation. - Severe bronchospasm: rare respiratory difficulty. - Hematologic abnormalities: rare blood count changes.

Before using Iberogas, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and seek medical advice. - Known allergies: avoid if hypersensitive to any listed botanical component. - Concomitant medications: discuss potential interactions with a physician. - Underlying medical conditions: use cautiously in hepatic or renal impairment. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Iberogas may interact with certain medicines; monitor accordingly.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - CYP450 substrates: possible alteration of drug metabolism. - Sedatives or CNS depressants: may enhance drowsiness. - Antidiabetic agents: could affect glucose control. - Antihypertensive drugs: may influence blood pressure response.